Cary Street Partners Investment Advisory’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $174K | Buy |
1,436
+281
| +24% | +$34K | 0.08% | 267 |
|
|
2025
Q1 | $129K | Buy |
1,155
+852
| +281% | +$95K | 0.07% | 269 |
|
|
2024
Q4 | $29.5K | Sell |
303
-8,620
| -97% | -$839K | 0.02% | 374 |
|
|
2024
Q3 | $1.03M | Sell |
8,923
-1,247
| -12% | -$143K | 0.04% | 366 |
|
|
2024
Q2 | $1.08M | Sell |
10,170
-278
| -3% | -$29.6K | 0.04% | 332 |
|
|
2024
Q1 | $1.01M | Buy |
10,448
+402
| +4% | +$38.9K | 0.04% | 339 |
|
|
2023
Q4 | $1.01M | Sell |
10,046
-391
| -4% | -$39.5K | 0.05% | 317 |
|
|
2023
Q3 | $1.06M | Buy |
10,437
+5,010
| +92% | +$510K | 0.06% | 297 |
|
|
2023
Q2 | $548K | Sell |
5,427
-1,620
| -23% | -$163K | 0.04% | 343 |
|
|
2023
Q1 | $648K | Buy |
7,047
+24
| +0.3% | +$2.21K | 0.05% | 301 |
|
|
2022
Q4 | $637K | Sell |
7,023
-273
| -4% | -$24.8K | 0.05% | 297 |
|
|
2022
Q3 | $555K | Buy |
7,296
+753
| +12% | +$57.3K | 0.05% | 295 |
|
|
2022
Q2 | $553K | Buy |
+6,543
| New | +$553K | 0.05% | 291 |
|
|
2021
Q3 | – | Sell |
-1,877
| Closed | -$171K | – | 289 |
|
|
2021
Q2 | $171K | Buy |
1,877
+770
| +70% | +$70.1K | 0.06% | 254 |
|
|
2021
Q1 | $95K | Sell |
1,107
-2,070
| -65% | -$178K | 0.04% | 241 |
|
|
2020
Q4 | $300K | Sell |
3,177
-58,259
| -95% | -$5.5M | 0.06% | 254 |
|
|
2020
Q3 | $5.34M | Buy |
+61,436
| New | +$5.34M | 1.13% | 16 |
|